drugset / Trial / NCT02865174

Topical Tranexamic Acid and Floseal® in Total Knee Arthroplasty

NCT02865174

Phase 4 Unknown 90 enrolled Chang Gung Memorial Hospital
RandomizedParallel-groupSingle-blindPrevention

Summary

Our purpose of this study is to conduct a prospective randomized controlled trial to investigate the blood-conservation effect of this two topical hemostatic agents in primary TKA procedures in patients with a risk of thromboembolic events. We will also observe if there is increased risk of thromboembolism by use of topical hemostatic agents.

Timeline

Start
2016-09
Primary completion
2017-08
Completion
2017-08

Publications

Drugs

EvaluationDrugModalityDoseRoute
Comparator Floseal Other / unclassified 10 ml Other
Comparator Tranexamic Acid Small molecule 3 g Other
Comparator Enoxaparin sodium Other / unclassified 40 mg Subcutaneous

Indications